OUR
CLINICAL STUDIES

Aminolock® Collagen is scientifically proven to be effective

Genacol continuously invests in medical research to demonstrate the beneficial health effects of its products. As a dominant player in the industry, we believe it’s important to continually surpass ourselves so we can offer the best products available on the market. Genacol’s proprietary Aminolock® Sequence Technology, the result of many years of research, helps improve the absorption of products by the body to maximize the beneficial effects.

As such, two independent studies have scientifically confirmed that Genacol helps maintain healthy joints.

These two trials, one carried out at the University of Liège (200 subjects), and the other one at the Veterans Memorial Medical Center Institution (113 subjects), have shown positive results. With Genacol, a “statistically significant” beneficial effect to maintain healthy joints was observed in the subjects: the best result that can be obtained during a clinical trial. To view the summary of the study, click here.

The study carried out at the University of Liege by Dr. Olivier Bruyère from the Department of Public Health, Epidemiology and Health Economics: ‘‘Effect of collagen hydrolysate in joint health: A 6-month randomized, double-blind, placebo controlled study’’ has just been published in the journal Complementary Therapies in Medicine. To view the summary of the study,  click here.

Both trials have confirmed the results of several other studies carried out in the past; revealing the beneficial effects of certain nutriments regarding joint health. Up to now, hydrolyzed collagen proves to be one of the most promising nutritional products.

DID YOU KNOW
Genacol collagen is the only product that has scientifically proven its efficiency with only 1.2 grams a day.